AMRX · Company research
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 20.295 | $6,494,978,790 | 6367341790.00 | 33.68197278911565 | — | 0.21433982683982689 | 8.1575022136481298 | 55.5221301931954180 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.